IP Library Granted Patent US 7,041,652
Granted Patent B1
US 7,041,652 · App. 09/763,602 · Granted May 9, 2006

Ascorbate-isoquercetin compositions

Assignee: Merck Patent GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,041,652
App. No.
09/763,602
Granted
May 9, 2006
Kind
B1
Abstract

The present invention relates to novel compositions containing ascorbic acid with an increased bioavailability of this vitamin. These compositions are useful as food supplements possessing preventive properties against damages of human organs, including skin, tissues and cells due to oxidative stress or damages.

Claims (10)

1. A method of extending the biological activity lifetime of ascorbic acid, ascorbate or a derivative thereof, comprising administering ascorbic acid, ascorbate or a derivative thereof in combination with one or more of quercetin-3-O-glucoside (isoquercetin), quercetin-4′-glucoside, quercetin-3′-glucoside, or quercetin-7-glucoside, in a molar ratio of from about 2:1 to about 1:2.

2. The method of claim 1 , wherein said ascorbic acid or ascorbate is present in an amount ranging from 150 to 1000 mg in a daily dose.

3. A method according to claim 1 wherein said isoquercetin is in combination with ascorbic acid or a physiologically active ascorbate in the form of its sodium, calcium, or other mineral or organic salt.

4. A method according to claim 1 wherein said isoquercetin is in combination with ascorbic acid or a mineral or organic salt thereof.

5. A method according to claim 1 wherein said combination further comprises a vitamin.

6. A method according to claim 1 wherein said combination further comprises a Mg, Ca, K, or Fe salt.

7. A method according to claim 1 wherein said combination further comprises a trace element.

8. A method according to claim 1 wherein said combination of ascorbic acid or ascorbate and isoquercetin is in a molar ratio of about 1:1.

9. A method according to claim 1 wherein said ascorbic acid or ascorbate is present in an amount ranging from 30 to 4000 mg in a daily dose.

10. A method according to claim 1 wherein said ascorbic acid or ascorbate is present in an amount ranging from 1500 to 3000 mg in a daily dose.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2012
From: MERCK PATENT GMBH
To: EUROPEAN BRAND PARTICIPATIONS SA
Reel/Frame 028968/0086 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2001
From: BUCHHOLZ, HERWIG; MEDUSKI, JERZY
To: MERCK PATENT GMBH
Reel/Frame 011977/0053 →